Skip to content

5-MeO-DMT clinical trials: pipeline by phase and status

Every trial in this library's ClinicalTrials.gov slice that names 5-MeO-DMT: 20 registered studies, grouped by phase and by recruitment status. For the published research, see the 5-MeO-DMT research page.

The pipeline at a glance

By phase
PhaseTrials
Early phase 1 1
Phase 1 11
Phase 1/2 2
Phase 2 4
Not applicable 1
Unspecified 1
By status
StatusTrials
Recruiting or planned 5
Active, not recruiting 2
Completed 12
Stopped 1

850 participants across the 20 trials that report enrollment. The earliest registered start is 2020, and 7 trials started in the last two years.

Most active sponsors

  • University Hospital, Basel, Switzerland 4 trials
  • Biomind Labs Inc. 3 trials
  • Universidade Federal do Rio Grande do Norte 3 trials
  • Algernon Pharmaceuticals 1 trial
  • Axial Therapeutic Research 1 trial

All 20 trials

Most advanced phase first, and within each phase the most recent start date first.

Phase 2 4 trials

Phase 1/2 2 trials

Phase 1 11 trials

Early phase 1 1 trial

Not applicable 1 trial

Unspecified 1 trial

  • Trifecta Research Study (opens in new tab)

    Active, not recruiting 52 participants Axial Therapeutic Research Started 2022

    PTSD - Post Traumatic Stress Disorder, Cognitive Dysfunction, Brain Injury, Depression - Major Depressive Disorder

Data from ClinicalTrials.gov (opens in new tab), refreshed daily. Browse all clinical trials.